Renaissance Capital logo

Sensing a difficult IPO market, Sensus Healthcare postpones $20 million IPO

March 30, 2016

Sensus Healthcare, which sells low-energy x-ray systems for treating non-melanoma skin cancer and keloids, postponed its IPO on Wednesday. It had filed to raise $20 million by offering 1.8 million shares at a price range of $10 to $12.

Only eight IPOs have priced in 2016, all in the healthcare sector, thanks to significant support from insiders. 

The Boca Raton, FL-based company was founded in 2010 and booked $10 million in sales for the 12 months ended December 31, 2015. It had planned to list on the Nasdaq under the symbol SRTSU. Joseph Gunnar & Co. and Feltl and Company were set to be the joint bookrunners on the deal.